Interní Med. 2001; 3(4): 178-180

Nefarmakologická léčba hypertrofické kardiomyopatie: je implantace pacemakeru přežitek z minulého tisíciletí nebo stále cenná léčebná strategie?

MUDr. Tomáš Mráz, prof. MUDr. Jan Lukl CSc
I. interní klinika FN a LF UP Olomouc

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mráz T, Lukl J. Nefarmakologická léčba hypertrofické kardiomyopatie: je implantace pacemakeru přežitek z minulého tisíciletí nebo stále cenná léčebná strategie? Interní Med. 2001;3(4):178-180.

Na kazuistickém sdělení je popsán postup při léčbě nemocné s hypertrofickou obstrukční kardiomyopatií a provedeno srovnání současných poznatků o možnostech a výsledcích nefarmakologické léčby tohoto závažného onemocnění.

Download citation

References

  1. Gadler F, Linde C, Daubert C, McKenna W, Meisel E, Aliot E, Guize L, Gras D. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J 1999 Jul;20 (14):1044-50. Go to original source... Go to PubMed...
  2. Meisel E, Raueolf T, Burghardt M, Kappenberger L. Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC study. Herz 2000 Jun;25(4):461-6. Go to PubMed...
  3. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy (M-PATHY). Circulation 1999 Jun 8; 99 (22): 2927-33. Go to original source... Go to PubMed...
  4. NishimuraRA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Alison TG. Dual-chamber pacing for hypertrofic cardiomyopathy: a ramdomized, double blind crossover trial. J Am Coll Cardiol 1997 Feb; 29 (2): 435-41. Go to original source... Go to PubMed...
  5. Linde C, Gadler F, Kappenberger L, Ryden L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC study group. Am J Cardiol 1999 Mar 15; 83 (6): 903-7. Go to original source... Go to PubMed...
  6. Sakai Y, Kawakami Y, Hirota Y, Ito T, Shimada S, Tokaji Y, Suwa M, Kawamura K. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a comparison of acute and chronic effects. Jpn Circ J 1999 Dec;Dec(12): 971-5. Go to original source... Go to PubMed...
  7. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995 July; 346: 211-214. Go to original source... Go to PubMed...
  8. Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 1999 Apr; 47 (2): 94-100. Go to original source... Go to PubMed...
  9. Faber L, Segewiss H, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998 Dec 1; 98 (22): 2415-21. Go to original source... Go to PubMed...
  10. Hirooka K, Zamagishi M, Miyatake K. Visualisation of ablated septal myocardium using myocardial contrast echocardiography in hypertrophic obstructive cardiomyopathy. Heart 2000 Oct; 84 (4): 382. Go to original source... Go to PubMed...
  11. Kuhn H, Gietzen FH, Leuner C, Schafers M, Schober O, Strunk-Muller C, Frieck M. Transcoronary ablation of septal hypertrophy: a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 2000; 89 Suppl 4: IV41-54. Go to original source... Go to PubMed...
  12. Lakkis NM. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one year follow-up. J Am Coll Cardiol 2000 Sep; 36 (3): 852-5. Go to original source... Go to PubMed...
  13. Merrill WH, Friesinger GC, Graham TP Jr, Byrd BF, Drinkwater DC, Christian DK. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2000 Jun; 69 (6): 1732-5. Go to original source... Go to PubMed...
  14. Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ. Comparison of dual chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999 Jul; 34 (1): 191-6. Go to original source... Go to PubMed...
  15. Maron BJ. Ventricular arrhytmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2000 Nov; 2 (6): 522-8. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.